tiprankstipranks
Advertisement
Advertisement
Dogwood sees cash runway into 4Q26
PremiumThe FlyDogwood sees cash runway into 4Q26
2M ago
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
Premium
The Fly
Dogwood reports Q4 EPS (26c) vs. ($6.29) last year
2M ago
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
Premium
Company Announcements
Dogwood Therapeutics Shareholders Approve Warrant Exercise Proposal
2M ago
Dogwood files to sell 6.43M shares of common stock for holders
PremiumThe FlyDogwood files to sell 6.43M shares of common stock for holders
4M ago
Dogwood Therapeutics Raises Capital via Registered Direct Financing
Premium
Company Announcements
Dogwood Therapeutics Raises Capital via Registered Direct Financing
4M ago
Dogwood announces financing of up to $26.8M
Premium
The Fly
Dogwood announces financing of up to $26.8M
4M ago
Strategic Acquisitions and Promising Trials Bolster Buy Rating for Dogwood Therapeutics
PremiumRatingsStrategic Acquisitions and Promising Trials Bolster Buy Rating for Dogwood Therapeutics
6M ago
Dogwood Therapeutics Advances Pain Treatment Pipeline
Premium
Company Announcements
Dogwood Therapeutics Advances Pain Treatment Pipeline
6M ago
Dogwood reports Q3 EPS ($8.20) vs ($2.05) last year
Premium
The Fly
Dogwood reports Q3 EPS ($8.20) vs ($2.05) last year
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100